Fundraising Fox
/People
Sign in

Maomeng Tong

Investor

Principal at INCE Capital

Chaoyang District, Beijing, China

Find your path to Maomeng

863 people in our graph can introduce you to Maomeng.

Each arrow is one introduction. Sign up to fill in the first one.

Ask JP Gan to introduce you to Maomeng

You →JP · together at INCE Capital (2022–2026) →Maomeng

Ask Jamie Chen to introduce you to Maomeng

You →Jamie · 5 people · together at INCE Capital →Maomeng

Ask Sam Okafor to introduce you to Maomeng

You →Sam · 3 people · together at David Geffen School of Medicine at UCLA →Maomeng

Sign up to find every way you can get introduced to Maomeng

  • Your email: the people you already email who know Maomeng
  • 2nd- and 3rd-degree connections: people you know who worked, studied or invested with Maomeng
  • Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

Sign up with GoogleAlready have an account? Log in

About

Maomeng Tong is a PhD pharmacologist with McKinsey and KKR experience who brings an end-to-end lab-to-commercialization and capital-markets perspective, specializing in cross-border biotech, medtech, therapeutic platforms, and surgical technologies.

Contact· self-published, not guessed

Invests in

AI & Machine LearningBiotechConsumerLogistics & Supply ChainRobotics

Experience

  1. INCE CapitalPrincipalcurrent2022 — presentSeattle, Washington, United States; Beijing, China
  2. Ronovo SurgicalBoard Observercurrent2025 — present
  3. Ronovo SurgicalDirector Board of Directors2024 — 2025Shanghai, China
  4. Avenzo TherapeuticsBoard Observercurrent2024 — present
  5. Allorion TherapeuticsBoard Membercurrent2023 — present
  6. KKR & Co. Inc.Principal2018 — 2022Beijing, China
  7. McKinsey & CompanyEngagement Manager2014 — 2018Greater China
  8. David Geffen School of Medicine at UCLAGraduate Student Researcher2009 — 2014

Skills & more

RBioinformaticsMetagenomicsGenomicsSystems BiologyNext Generation SequencingMergers & AcquisitionsIntegration PlanningMedical DevicesVertical IntegrationSpin-offsEnergy Efficiency
+1 moreMerger management

Languages Chinese · English

From Maomeng's professional profile.

Colleagues at INCE Capital

Bobby DeYoung
Director of Analytics, Reporting and Compliance at Kirenaga Partners
Jireh Li
Partner at INCE Capital
JP Gan
Founding Partner at INCE Capital
Paul Keung
Founding Partner and COO at INCE Capital
Stella Zhou
Founding Partner at INCE Capital
Steven Hu
Founding Partner at INCE Capital
Tank Tang
Principal at INCE Capital
Zhen Xia
Principal at INCE Capital

Frequently asked questions

Who is Maomeng Tong?
Maomeng Tong is a PhD pharmacologist with McKinsey and KKR experience who brings an end-to-end lab-to-commercialization and capital-markets perspective, specializing in cross-border biotech, medtech, therapeutic platforms, and surgical technologies.
Where does Maomeng Tong work?
Maomeng Tong is Principal at INCE Capital.
What does Maomeng Tong invest in?
Maomeng Tong invests in AI & Machine Learning, Biotech, Consumer, Logistics & Supply Chain, Robotics.
Where did Maomeng Tong go to school?
Maomeng Tong studied at UCLA (Ph.D., Molecular and Medical Pharmacology); Tsinghua University (B.S., Biological Science & Economics).

Same school

Shared employers

Also worked at Allorion Therapeutics1

Fang LiFounder at Allorion Therapeutics